ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
AstraZeneca transfers rights for Eklira and Duaklir to Covis Pharma EuropeanPharmaceuticalReview
November 05, 2021AstraZeneca has agreed to transfer its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and Duaklir (aclidinium bromide/formoterol) to Covis Pharma. -
Circassia pulls plug on AZ agreement pharmatimes
April 10, 2020Circassia Pharmaceuticals is pulling back from its development and commercialisation agreement with AstraZeneca for US commercial rights to COPD therapies Tudorza (aclidinium) and Duaklir (aclidinium/formoterol).
Pharma Sources Insight January 2025
